Silexion Therapeutics
SLXN----
Silexion Therapeutics (SLXN)
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat maligna...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Silexion Therapeutics Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$60.002543.17%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Unusual Whales · Jun 25 at 01:21 PM
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
- StockTitan · Jun 22 at 11:40 PM
Silexion Therapeutics Receives Approval from Germany's BfArM to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer | SLXN Stock News
- PUBT · Jun 22 at 07:38 AM
Silexion Therapeutics presentation highlights SIL204 siRNA program targeting KRAS-driven pancreatic cancer
- StockTitan · Jun 16 at 07:30 AM
Silexion Therapeutics to Attend BIO International Convention 2026 | SLXN Stock News
- Unusual Whales · Jun 4 at 06:57 PM
Silexion Therapeutics Announces 1-for-10 Reverse Share Split
- benzinga_article · May 26 at 08:03 AM
Silexion Therapeutics shares are trading lower after the company announced a 1-for-10 reverse share split.
